Ex-Div Reminder For Gladstone Commercial (GOOD)

Looking at the universe of stocks we cover at Dividend Channel, on 4/18/13, Gladstone Commercial Corp (GOOD) will trade ex-dividend, for its monthly dividend of $0.125, payable on 4/30/13. As a percentage of GOOD's recent stock price of $19.78, this dividend works out to approximately 0.63%, so look for shares of Gladstone Commercial Corp to trade 0.63% lower — all else being equal — when GOOD shares open for trading on 4/18/13.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for GOOD, showing historical dividends prior to the most recent $0.125 declared by Gladstone Commercial Corp:

GOOD+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from GOOD is likely to continue, and whether the current estimated yield of 7.58% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of GOOD shares, versus its 200 day moving average:

Gladstone Commercial Corp 200 Day Moving Average Chart

Looking at the chart above, GOOD's low point in its 52 week range is $15.56 per share, with $20.78 as the 52 week high point — that compares with a last trade of $19.78.

In Tuesday trading, Gladstone Commercial Corp shares are currently up about 0.7% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says